Information Provided By:
Fly News Breaks for May 14, 2015
INCY
May 14, 2015 | 08:50 EDT
SunTrust believes that the data for Incyte's JAK1/PI3K combination in NHL and HL is promising. The firm says that the combo shows early signs of activity in B cell malignancies. It keeps a $120 price target and Buy rating on the shares.
News For INCY From the Last 2 Days
There are no results for your query INCY